Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shenyang Xingqi Pharmaceutical (300573 CH)
Watchlist
19
Analysis
Health Care
•
China
Shenyang Xingqi Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, produces, and distributes ophthalmic medicines including anti-bacterial products, allergy medicines, cataract preventions, and glaucoma treatments.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Zhaoke Ophthalmology Pharmaceutical
•
15 Apr 2021 14:18
Zhaoke Ophthalmic (兆科眼科) Pre-IPO: Beware of Aggressive "Guidance"
We did research on its key competitor in the CsA segment and think that Frost & Sullivan grossly underestimates the competition and overestimates...
Ke Yan, CFA, FRM
Follow
362 Views
Share
bearish
•
Zhaoke Ophthalmology Pharmaceutical
•
09 Mar 2021 09:28
Pre-IPO Zhaoke Ophthalmology Pharmaceutical - It Remains to Be Seen How to Find Its Way Out
The article analyzed Zhaoke Ophthalmology in terms of pipeline, competitive landscape, financial position and also included concerns for the future...
Xinyao (Criss) Wang
Follow
540 Views
Share
bullish
•
HBM Holdings Limited
•
02 Dec 2020 09:36
Harbour Biomed IPO: Positive Thoughts in Brief
This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.
Kemp Dolliver, CFA
335 Views
Share
bullish
•
HBM Holdings Limited
•
01 Dec 2020 09:34
Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"
This article analyzed Harbour's core products, team, technology platforms, thoughts on valuation and the "hidden" value that is often easy to be...
Xinyao (Criss) Wang
Follow
319 Views
Share
First
Previous
1
2
3
4
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x